Unity Biotechnology, Inc. Lessee, Operating Lease, Liability, to be Paid
Unity Biotechnology, Inc. had Lessee, Operating Lease, Liability, to be Paid of $26.02 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-04-22
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid $26.02M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $27.30M.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid $28.55M.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid $29.79M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-03-31 | $26.02M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $27.30M 10-K · filed 2025-03-07 |
| 2024-09-30 | $28.55M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $29.79M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $31.03M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $32.27M 10-K · filed 2024-04-15 |
| 2023-09-30 | $33.48M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $34.68M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $35.88M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $37.08M 10-K · filed 2023-03-15 |
| 2022-09-30 | $38.25M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $39.94M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $41.66M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $43.36M 10-K · filed 2022-03-15 |
| 2021-09-30 | $45.04M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $46.70M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $48.36M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $50.01M 10-K · filed 2021-03-23 |
| 2020-09-30 | $51.64M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $53.25M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $54.97M 10-Q · filed 2020-05-07 |